Pricing
Cyanvac
Contact
No bio yet
Hong Jin
Chief Scientific Officer
Hank Radziewicz
Md, Mscr
This person is not in any teams
This person is not in any offices
Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.
Industries
Headquarters
Links
ARL Bio Pharma
Dash Bio
Cipla
Spectrum Solutions®
Paragon Therapeutics, Inc.
View more